Vimarsana
Biggest News Aggregation in the World

Page 21 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

Acasti Pharma (NASDAQ:ACST) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS - Vimarsana News

Acasti Pharma (NASDAQ:ACST) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Acasti Pharma (NASDAQ:ACST – Get Free Report) released its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.02, MarketWatch Earnings reports. Acasti Pharma Stock Down 6.1 % Shares of Acasti Pharma stock opened at $2.45 on Wednesday. Acasti Pharma has a 1 […]

ESSA Pharma Inc (EPIX) Reports Q1 Fiscal 2024 Financial Results - Vimarsana News

ESSA Pharma Inc (EPIX) Reports Q1 Fiscal 2024 Financial Results

Continued Clinical Progress and Strong Cash Position Highlighted

Source: yahoo.com
MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimates - Vimarsana News

MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimates

MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of -13.70% and 100%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Source: yahoo.com
MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights - Vimarsana News

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

SAN DIEGO--(BUSINESS WIRE)--MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today reported results for the three and six months ended December 31, 2023, and highlighted recent corpor...

Evoke Pharma Announces Closing of $7.5 Million Public Offering - Vimarsana News

Evoke Pharma Announces Closing of $7.5 Million Public Offering

SOLANA BEACH, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily ...